Abdo A Elfiky

InstitutionCairo University
AddressGiza
Egypt
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 20 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 27 publications over 8 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gyebi GA, Elfiky AA, Ogunyemi OM, Ibrahim IM, Adegunloye AP, Adebayo JO, Olaiya CO, Ocheje JO, Fabusiwa MM. Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum. Comput Biol Med. 2021 09; 136:104671. PMID: 34332348.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    2. Mahmud S, Elfiky AA, Amin A, Mohanto SC, Rahman E, Acharjee UK, Saleh A. Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective. Future Virol. 2021 Jun. PMID: 34290822.
      Citations: 1     
    3. Sonousi A, Mahran HA, Ibrahim IM, Ibrahim MN, Elfiky AA, Elshemey WM. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Pharmacol Rep. 2021 Dec; 73(6):1754-1764. PMID: 34165771.
      Citations: 1     Fields:    Translation:HumansCells
    4. Ibrahim IM, Elfiky AA, Elgohary AM. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective. Biochem Biophys Res Commun. 2021 07 12; 562:89-93. PMID: 34049205.
      Citations: 6     Fields:    Translation:HumansCells
    5. Elfiky AA, Ibrahim IM. Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico. J Infect. 2021 May; 82(5):186-230. PMID: 33493496.
      Citations: 9     Fields:    Translation:HumansCells
    6. Elfiky AA, Azzam EB, Shafaa MW. The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico. Mol Divers. 2021 Jan 03. PMID: 33389441.
      Citations: 2     Fields:    
    7. Elfiky AA, Ibrahim IM, Amin FG, Ismail AM, Elshemey WM. COVID-19 and Cell Stress. Adv Exp Med Biol. 2021; 1318:169-178. PMID: 33973178.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    8. Elfiky AA. SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses. Front Pharmacol. 2020; 11:577467. PMID: 33362542.
      Citations: 10     
    9. Ismail AM, Elfiky AA. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic. Signal Transduct Target Ther. 2020 10 30; 5(1):252. PMID: 33127886.
      Citations: 4     Translation:HumansCellsPHPublic Health
    10. Abu-Melha S, Edrees MM, Riyadh SM, Abdelaziz MR, Elfiky AA, Gomha SM. Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro). Molecules. 2020 Oct 06; 25(19). PMID: 33036293.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    11. Elfiky AA, Ibrahim IM, Ismail AM, Elshemey WM. A possible role for GRP78 in cross vaccination against COVID-19. J Infect. 2021 02; 82(2):282-327. PMID: 32920062.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    12. Elfiky AA, Baghdady AM, Ali SA, Ahmed MI. GRP78 targeting: Hitting two birds with a stone. Life Sci. 2020 Nov 01; 260:118317. PMID: 32841659.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    13. Adem S, Eyupoglu V, Sarfraz I, Rasul A, Zahoor AF, Ali M, Abdalla M, Ibrahim IM, Elfiky AA. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine. 2021 May; 85:153310. PMID: 32948420.
      Citations: 12     Fields:    Translation:Cells
    14. Elfiky AA. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. J Biomol Struct Dyn. 2021 06; 39(9):3204-3212. PMID: 32338164.
      Citations: 67     Fields:    Translation:HumansCells
    15. Elfiky AA. Natural products may interfere with SARS-CoV-2 attachment to the host cell. J Biomol Struct Dyn. 2021 06; 39(9):3194-3203. PMID: 32340551.
      Citations: 47     Fields:    Translation:HumansCells
    16. Elfiky AA, Azzam EB. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. J Biomol Struct Dyn. 2021 05; 39(8):2923-2931. PMID: 32306854.
      Citations: 11     Fields:    Translation:Cells
    17. Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 2020 Jul 15; 253:117592. PMID: 32222463.
      Citations: 260     Fields:    Translation:HumansCells
    18. Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA. COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect. 2020 05; 80(5):554-562. PMID: 32169481.
      Citations: 170     Fields:    Translation:HumansCellsPHPublic Health
    19. Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020 May 01; 248:117477. PMID: 32119961.
      Citations: 229     Fields:    Translation:HumansCells
    20. Ogunyemi OM, Gyebi GA, Elfiky AA, Afolabi SO, Ogunro OB, Adegunloye AP, Ibrahim IM. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective. Antivir Chem Chemother. 2020 Jan-Dec; 28:2040206620984076. PMID: 33372806.
      Citations: 3     Fields:    Translation:HumansCells
    21. Elfiky AA, Mahdy SM, Elshemey WM. Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. J Med Virol. 2017 06; 89(6):1040-1047. PMID: 27864902.
      Citations: 43     Fields:    Translation:Cells
    Elfiky's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (119)
    Explore
    _
    Co-Authors (42)
    Explore
    _
    Similar People (60)
    Explore
    _